NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Update

NewGenIvf Group Limited (NASDAQ:NIVF) saw a significant increase in short interest in the month of June. As of June 30th, there was short interest totaling 654,534 shares, an increase of 631.2% from the June 15th total of 89,521 shares. Approximately 28.6% of the company’s stock are sold short. Based on an average daily volume of 18,460,916 shares, the short-interest ratio is currently 0.0 days.

Insiders Place Their Bets

In other NewGenIvf Group news, major shareholder Financial Lp Hrt sold 28,439 shares of the stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $2.40, for a total value of $68,253.60. Following the completion of the transaction, the insider owned 18,187 shares in the company, valued at approximately $43,648.80. This represents a 60.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 31.80% of the stock is currently owned by insiders.

NewGenIvf Group Stock Down 2.3%

NASDAQ:NIVF traded down $0.03 during trading hours on Monday, reaching $1.37. The company had a trading volume of 69,313 shares, compared to its average volume of 986,134. The company has a current ratio of 3.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.16. The firm’s 50 day moving average price is $2.39 and its 200-day moving average price is $8.72. NewGenIvf Group has a 52 week low of $1.19 and a 52 week high of $624.60.

NewGenIvf Group (NASDAQ:NIVF) last released its quarterly earnings results on Tuesday, March 31st. The company reported ($861.72) earnings per share for the quarter. The firm had revenue of $1.42 million during the quarter. As a group, equities analysts expect that NewGenIvf Group will post 14.22 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

NIVF has been the subject of several analyst reports. Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a report on Monday, April 27th. Wall Street Zen upgraded shares of NewGenIvf Group to a “hold” rating in a research note on Saturday, July 4th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, NewGenIvf Group has a consensus rating of “Sell”.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.